Dr Lalchandani Labs Chart
Dr Lalchandani Labs Share Key Metrics
Volume
0.00
Market Cap
8.33 CR
LTQ@LTP
0@9.61
ATP
0
Var Margin
53.5 %
Circuit Range
9.13-10.09
Delivery %
100 %
Value
0.00
ASM/GSM
No
Market Lot
4000
Summary
Dr Lalchandani Labs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
53.46
Sector P/B
-16.25
Sec. Div. Yield
2.21
Dr Lalchandani Labs Resistance and Support
Pivot 9.49
Resistance
First Resistance
9.73
Second Resistance
9.85
Third Resistance
10.09
Support
First Support
9.37
Second Support
9.13
Third Support
9.01
Dr Lalchandani Labs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-01-20 | Rights issue of Equity Shares |
Dr Lalchandani Labs News
Dr Lalchandani Labs Ltd - 541299 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Dr Lalchandani Labs announced the resignation of Mrs. Saniya Hussain from the position of Company Secretary and Compliance Officer, effective April 22, 2026. She cited personal/professional reasons for her departure.
Apr 22 2026 16:04:00
About Dr Lalchandani Labs AboutThe
NSE : 0
BSE : 541299
ISIN : INE871Z01013
The Company was originally incorporated as partnership firm at New Delhi vide Partnership Agreement dated 15th Day of September 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited incorporated under the provisions of Companies Act 2013 vide certificate of Incorporation dated 2nd August 2017 issued by the Registrar of Companies Delhi vide agreement dated 31st August 2017. The Corporate Identification Number of the Company is U85320DL2017PLC321605.MAJOR EVENTS AND MILESTONESAugust 2017- Incorporation of the Company in the name and style of "Dr Lalchandani Labs Limited" to takeover the Existing Partnership Firm.August 2017- Entered into an Agreement for takeover of the Existing partership Firm named on going concern basis Dr A Lalchandani Pathology LaboratariesJanuary 2018- Entered in to an Agreement for purchase of acquiring office premises at J-23 Block-J Lajpat Nagar-III New Delhi for consideration other than cash from promoter Mr. Arjan Lal Chandani
Dr Lalchandani Labs Management
| Name | Position |
|---|---|
| Arjan Lalchandani | Chairman & Managing Director |
| Mohit Lalchandani | Whole Time Director & Chief Executive Officer |
Dr Lalchandani Labs Similar Stocks
Ortin Global Ltd.
14.50
0.00 (0.00%)
Hindustan Bio Sciences Ltd.
9.45
0.19 (2.05%)
Kabra Drugs Ltd.
25.00
-0.05 (0.20%)
Dhanvantri Jeevan Rekha Ltd.
26.32
0.00 (0.00%)
Dolphin Medical Services Ltd.
5.63
0.00 (0.00%)
Decipher Labs Ltd.
7.85
-0.02 (0.25%)
Transpact Enterprises Ltd.
200.00
0.00 (0.00%)
MPS Pharmaa Ltd.
0.00
0.00 (0.00%)
Dr Lalchandani Labs FAQs
